We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Gastroenterology

Journal Scan / Research · September 07, 2016

Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir /Ritonavir /Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C

Gastroenterology

 

Additional Info

Gastroenterology
Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System
Gastroenterology 2016 Sep 01;151(3)457-471.e5, GN Ioannou, LA Beste, MF Chang, PK Green, E Lowey, JI Tsui, F Su, K Berry

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading